GSAHULO ADS!

Coronavirus Updates : Over Fifteen (15) Nigerians Hospitalized due to excessive use of Chloroquine







Reports shows that some Nigerians have been hospitalized for chloroquine poisoning based on US president Donald Trump's statement that chloroquine can be used to treat people with coronavirus infection.

After taking overdose of the anti-malarial drug, about 20 Nigerians living in Lagos are currently hospitalized in various hospitals in the state, Leadership notes.

One of the cases reported by the newspaper involves a family of five who were hospitalized as a result of chloroquine poisoning in a private hospital's intensive care unit.

A medical doctor who does not want to be called, reported that after taking chloroquine without prescription, several people were rushed to the hospital on an emergency.



He said people who haven't checked the coronavirus positively took the anti-malaria drug based on unconfirmed speculation that chloroquine would cure COVID-19.

The Lagos state government also reported the development when the state governor's chief press secretary, Gboyega Akosile, cited comments from senior health special assistant, Dr. Oreoluwa Finnih, that some state hospitals are now treating patients who have taken so much quantities of chloroquine, leading to intoxication.

Similarly, the Nigeria Center for Disease Control (NCDC) has warned nationals of the use of chloroquine, a pill famed for malaria cure, to treat the dreaded disease called coronavirus.

On its official Twitter account on Friday 20 March, Nigerians were told that the use of the medication was subject to World Health Organization(WHO) approval.

The agency said the global health body has yet to give its opinion about chloroquine as a means of eradicating the global pandemic.



This added that scientists are currently "working hard to confirm the protection of many medicines for this disease."

In another article, amid the spread of the coronavirus and the vigilant quest for therapies and cure, the National Agency for Food and Drug Administration and Control (NAFDAC) on Friday, March 20, reported the approval of chloroquine development for clinical trials.

According to Channels TV, Mojisola Adeyeye, head of NAFDAC, announced this at the agency's headquarters in Lagos state.

However, Adeyeye specifically indicated that chloroquine is not being approved by NAFDAC as a treatment for the deadly virus but to find a treatment for COVID-19 in clinical trials.

While calling for experts and researchers involved in doing clinical trials, Adeyeye clarified that for this reason only one company was approached to produce a batch of chloroquine.

PLEASE SHARE THIS ARTICLE WITH YOUR FRIENDS ON YOUR SOCIAL MEDIA HANDLES,AND ALSO LIKE OUR FACEBOOK PAGE BELOW!.

Post a comment

0 Comments